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Abstract
Purpose—To identify challenges and solutions to the efficient conduct of a multi-site, practice-
based randomized controlled trial to improve nurses’ adherence to personal protective equipment 
use in ambulatory oncology settings.
Design—The Drug Exposure Feedback and Education for Nurses’ Safety (DEFENS) study is a 
clustered, randomized, controlled trial. Participating sites are randomized to web-based feedback 
on hazardous drug exposures in the sites plus tailored messages to address barriers versus a control 
intervention of a web-based continuing education video.
Approach—The study principal investigator, the study coordinator, and two site leaders 
identified challenges to study implementation and potential solutions, plus potential methods to 
prevent logistical challenges in future studies.
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Findings—Noteworthy challenges included variation in human subjects protection policies, 
grants and contracts budgeting, infrastructure for nursing-led research, and information technology 
variation. Successful strategies included scheduled web conferences, site-based study champions, 
site visits by the principal investigator, and centrally-based document preparation. Strategies to 
improve efficiency in future studies include early and continued engagement with contract 
personnel in sites, and proposed changes to the common rule concerning human subjects. The 
DEFENS study successfully recruited 393 nurses across 12 sites. To date, 369 have completed 
surveys and 174 nurses have viewed educational materials.
Conclusions—Multi-site studies of nursing personnel are rare and challenging to existing 
infrastructure. These barriers can be overcome with strong engagement and planning.
Clinical Relevance—Leadership engagement, onsite staff support, and continuous 
communication can facilitate successful recruitment to a workplace-based randomized, controlled 
behavioral trial.
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Intervention research; survey methodology; Environmental health; Work environment; Education
Multi-site research is an important strategy to strengthen the external validity of nursing 
science (O’Mara, Bauer-Wu, Berry, & Lillington, 2007). In contrast to single-site studies, 
research projects conducted with multiple sites offer potentially larger, more diverse 
participants samples and reduce the likelihood of idiosyncratic research findings. 
Conversely, multi-site studies are more complicated to conduct and administer. New 
complexities also arise when research participants are staff, as opposed to patients or clients.
Workplace intervention studies are increasing, due in part to growing awareness that 
improved worker health and safety has downstream societal benefits (Anger et al., 2015). 
Specifically, the National Institute for Occupational Safety and Health (NIOSH) has 
launched the Total Worker Health initiative to respond to this challenge (National Institute 
for Occupational Safety and Health (NIOSH), 2016; Weisfeld, Lustig, & Board of Health 
Sciences Policy, 2014). Healthy workers are associated with lower turnover, improved 
economic productivity, and enhanced personal wellbeing. Due to labor shortages, high 
acuity, long shifts, and physical demands, NIOSH has identified healthcare workers as a 
vulnerable labor sector for intervention (National Institute for Occupational Safety and 
Health (NIOSH), 2013). For the past ten years, our interdisciplinary team has documented 
the specific concerns of oncology nurses employed in ambulatory oncology settings. These 
nurses face an unusual occupational threat of hazardous drug exposure given the high patient 
volume, the explicit emphasis on chemotherapy treatment and associated continuous risks of 
exposure.
Our team has documented that 18 percent of surveyed ambulatory oncology nurses 
experienced an unplanned hazardous drug spill in the past six months (Friese et al., 2014). 
Hazardous drug exposure is correlated with substantial short- and long-term health effects, 
such as nausea, vomiting, airway irritation, reproductive problems, and rare cancers 
(National Institute for Occupational Safety and Health, 2004). Despite 30 years of data to 
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support the need for increased vigilance when handling hazardous drugs, surprisingly few 
nurses wear personal protective equipment as recommended (Connor & McDiarmid, 2006; 
Polovich & Clark, 2012). Except for the current project, only one published study examined 
an educational intervention for nurses, conducted in one Malaysian hospital (Keat, Sooaid, 
Yun, & Sriraman, 2013). Thus, we lack sufficient evidence on how to improve nurses’ use of 
personal protective equipment when handling hazardous drugs.
The Drug Exposure Feedback and Education for Nurses’ Safety (DEFENS) study is a four-
year, multi-site cluster randomized controlled trial (Friese, Mendelsohn-Victor, et al., 2015). 
The study compares one-time static educational information about hazardous drug exposure 
prevention to quarterly feedback on study results, coupled with tailored messages designed 
to reduce barriers to protective equipment use. In planning for the project, we reviewed the 
sparse literature that describes multisite research project management with registered nurse 
employees as participants. In the current paper, we review successful study implementation 
strategies and identify important considerations for future research projects that plan to 
incorporate nurses as participants.
Approach
The DEFENS study is a cluster randomized controlled trial. Nurses who work 16 hours a 
week or more in ambulatory infusion within 12 large cancer centers in the United States 
were invited to participate. Full details may be found in the published protocol paper (Friese, 
Mendelsohn-Victor, et al., 2015) or in the ClinicalTrials.gov registry (National Institutes of 
Health, 2016a). Guided by extant models of health behavior and risk reduction, we 
hypothesized that one-time educational content is insufficient to improve nurses’ use of 
personal protective equipment when handling hazardous drugs (McCullagh, Ronis, & Lusk, 
2010). Rather, we compared static educational content (control intervention) to quarterly 
feedback about data gleaned from study, coupled with video messages tailored to 
participants’ reported barriers to protective equipment use (experimental intervention). To 
avoid within clinic contamination, randomization occurred at the site level, stratified for 
clinic size and baseline use of personal protective equipment. The primary endpoint is nurse-
reported use of personal protective equipment following one year of education or feedback 
plus tailored messages, using a validated self-report instrument (Polovich & Martin, 2011). 
To assess intervention fidelity, our team monitored participants’ frequency of accessing web-
based materials and the duration of time they viewed website content.
Nurses also provided prospective reports of hazardous drug spills for quarterly analyses 
(delivered to the sites assigned to experimental intervention). Secondary analyses included 
measuring hazardous drug exposures in nurses’ plasma, as well as correlative analyses of 
immune and reproductive function. Informed consent, study questionnaires, educational 
content, and feedback content were housed on an encrypted, user-authenticated website.
For the present inquiry, study team members identified key challenges to study operations 
and strategies to assure study success. Team members also identified persistent and 
emerging issues for future investigators and participating site personnel to consider when 
embarking on a multi-site research study involving nursing personnel. To evaluate our study 
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procedures, we constructed a flow diagram for participant and recruitment, as recommended 
by the Consolidated Standards of Reporting Trials (CONSORT) (Campbell, Piaggio, 
Elbourne, Altman, & CONSORT Group, 2012).
Findings
Leadership Engagement
Congruent with the implementation science literature (Yevchak et al., 2014), as well as 
organizational change theory (Tropman & Wooten, 2010), our team identified that 
endorsement and ongoing support by the senior nursing executive was crucial for success. 
Senior nursing leadership engagement facilitated timely protocol activation and encouraged 
clinical nurses to participate. Engagement began before the proposal was submitted and 
continues on period intervals throughout the project.
Before the original grant proposal was submitted, the principal investigator (PI) contacted 
senior nurse executives from National Cancer Institute-designated comprehensive cancer 
centers. He presented an overview of the proposed project at their annual meeting. He led 
one-hour informational webinars that reviewed the study team’s preliminary data and 
outlined the proposed research project. He prepared 5-page executive summaries for these 
leaders to share with their institution’s senior leadership. On several occasions, feedback 
from these executives led to important study protocol changes. For example, one leader 
recommended reviewing the policies of all participating institutions for differences in 
hazardous drug handling policy. Another identified strategies for nurses in satellite locations 
to participate.
After a favorable peer-review process by NIOSH’s study section, the PI re-engaged with 
interested leaders to plan for study activation. Re-engagement enabled leaders to identify 
key contacts, budgetary considerations, and information technology needs for participation. 
After re-engagement, several supportive leaders declined participation, principally due to 
major organizational changes in cancer care services and/or electronic health record 
implementation. The PI was able to replace these sites by contacting chief nursing officers 
from other cancer centers.
To demonstrate leadership support of the project to potential participants, we drafted study 
letter endorsements that would be sent to eligible staff nurses on behalf of the nurse leaders. 
The study team and the nursing leaders agreed that study participants would remain 
anonymous to the nurse leaders in the institution to promote trust in the study and ensure 
confidentiality of responses as well as of personal health information from employers.
Human Subjects Protections
Institutional review boards (IRBs) have extensive experience in protecting human subjects 
who are patients in a health care facility. They have less experience when employees are 
participants, and the interventions are not of a clinical nature. Timely, thorough, and efficient 
human subjects review was a critical priority for the study team. In partnership with leaders 
of our institution’s IRB, we carefully reviewed the criteria for “not-engaged” status for 
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participating sites. An institution can be considered “not engaged” if the involvement of their 
employees or their agents is limited, among other things, to the following criteria:
a. the services performed do not merit professional recognition or publication 
privileges;
b. the services performed are typically performed by those institutions for non-
research purposes; and
c. the institution’s employees or agents do not administer any study intervention 
being tested or evaluated under the protocol (US Department of Health and 
Human Services Office of Human Research Protections, 2016).
The advantage of not-engaged status meant that our protocol would be reviewed, critiqued, 
and approved centrally, that informed consent documents would be standardized, and 
administrative workloads would be reduced for participating sites. Another option to retain 
centralized control was to have site IRB cede control to the University by completing an IRB 
Authorization Agreement (IAA) form (National Academies of Science, Engineering, and 
Medicine, 2016).
Our initial approach was to review our IRB’s determination of not-engaged status with each 
site, provide requisite documentation, and ask them to confer with their IRB. We offered to 
speak with IRB staff, and highlight that participants were employees, not patients, the 
intervention was behavioral in nature, and a data safety monitoring board was in place at the 
primary institution in the event of an adverse event. In six cases, the participating sites’ IRBs 
agreed with our interpretation. In three cases, participant sites’ IRBs ceded authority to our 
institution’s IRB. In three cases, the participating institution required full review by their 
IRB. In the three latter cases, the study team provided as much assistance in preparing 
documents for review as possible. The time between initial IRB approval and final IRB 
approval at the last research site was 11 months.
The shift to not-engaged status required the team to modify several study procedures from 
our original plan. The coordinators at each site were no longer responsible for direct 
participant recruitment. Their role shifted to study facilitation, as they provided information, 
resources, and assisted participants with website navigation. Informed consent took place on 
the study website. Questions regarding consent and the study protocol were directed to the 
study personnel at the primary site. The downside of this approach is study coordinators did 
not know which nurses were enrolled in the study and could not provide personal reminders 
to complete study activities. A full-time project manager at the primary site was essential to 
manage participant inquiries.
Benefits of On-Site Study Coordinators
We asked each site to name at least one registered nurse to serve as a study coordinator. In 
most cases, the grant provided financial resources to the institution to partially subsidize the 
hours coordinators spent. These individuals provided information about the study to 
participants and clinic leaders, coordinated logistics of site visits, identified where and how 
blood would be drawn at each site, and directed participants to complete surveys and have 
blood drawn, when applicable.
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To support these study coordinators, the project manager prepared a binder with all study 
materials, including the full protocol, a clean copy of the consent form, and a document of 
frequently-asked questions. These materials were updated as necessary, based on feedback 
from the study coordinators. The primary site also held 4 recorded webinars to review study 
procedures, answer questions, and address concerns. The primary site has held webinars 
approximately quarterly to keep study coordinators informed on study progress, address any 
ongoing challenges, and maintain enthusiasm for the project. We took steps to reduce the 
potential for cross-site contamination. After sites were randomized to intervention or control 
arms, separate telephone calls were held with study coordinators based on their 
randomization status. We also stressed to participants and study coordinators that all 
participants will learn the results of the study before the project concludes.
Finally, the PI and/or project manager conducted visits to all 12 sites at the time of study 
activation; another site visit occurs close to the primary endpoint collection time point. This 
visit enabled the PI and project manager to educate staff and engage nurses at each site in 
the study. It was also an opportunity to connect with study coordinators, thank them for their 
support, and outline logistics of study accrual and intervention procedures. Study 
coordinators were instrumental in arranging these visits and encouraging staff to attend 
information sessions with the study personnel.
Study coordinators assisted the project by troubleshooting reasons for low participation rates 
in educational video viewing. Study coordinators identified technology challenges and time 
constraints as barriers to timely completion. Coordinators also challenged our assumption 
that staff members would complete study activities after hours at home. They suggested 
communal “viewing parties” during scheduled work breaks with refreshments to facilitate 
completion. We also modified delivery of the materials to facilitate easy viewing based on 
their feedback. These suggestions were associated with improving our participation rate 
from 17.4% to 60.8% at the time of this publication.
Internet Access and Browser Compatibility
Advantages of Web-based study platforms include the capacity to standardize delivery, 
monitor access, and adjust content as needed. Our team experienced substantial challenges 
with the variation in informational technology and security restrictions across twelve 
participating sites. Despite substantial user testing before the project website launched, 
several institutions continued to use outdated and unsupported web browsers during the 
study period. This required unplanned modifications to the website design and scaled-down 
versions of materials for participants in affected sites. In addition to website browser 
incompatibility, several sites restricted the kinds of files staff members could access on clinic 
computers. Although we provided each site’s informational technology departments with 
web addresses in advance, several sites blocked viewing of video materials, regardless of 
source. For participants unable to access the videos, our team created one-page handouts that 
summarized the video content. To reduce the burden of using the website, we used 
Qualtrics™ (Provo, UT) software to deliver videos and handouts directly to participants’ 
email accounts.
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Financial management of federally-supported multi-site projects intersect federal policy, 
primary site institutional policy, in addition the policies of participating sites. These policies 
are not always congruent. Moreover, grants and contract personnel occasionally do not 
understand the scope of work planned for the sites. In addition, policy changes that occur 
during the awards process require planning, attention, and flexibility by the primary research 
team.
In the case of the DEFENS study, the Department of Health and Human Services modified 
their policy in 2014, between the time of our original proposal and budget submission 
(Office of Management and Budget, 2014). The PI requested budgets from each site in the 
pre-award phase, with the expectation of no indirect costs included. However, after the 
policy change, participating institutions now expected full indirect costs in addition to their 
originally submitted budget. Yet the funds provided by the Centers for Disease Control and 
Prevention did not provide funds to support the work, plus full indirect costs at the 
participating sites.
The PI, in partnership with senior nurse executives at each site, engaged in discussions with 
respective grants and contracts departments to request waivers for full indirect costs for the 
project. These waiver requests highlighted the unique study focus on employees, not 
patients, the not-engaged human subjects determination for most sites, and the institutional 
benefits to participation. Whenever possible, the PI pledged non-financial resources to 
support sites with study activities, including primary site preparation of any requisite 
documents and on-site assistance with participant enrollment. In addition, the project 
manager assumed primary responsibility for several functions we anticipated study 
coordinators to assume. Fortunately, we prevailed in all twelve site negotiations. However in 
the future, closer consultation with grants and contracts offices in the pre-award phase 
should help clarify roles and expectations.
Enrollment and Participation Rates
Figure 1 shows the CONSORT diagram of study participants. The number of participants is 
slightly uneven in arms because sites, not participants, were randomized. Of 440 registered 
nurses identified by sites that met eligibility criteria, 393 completed the informed consent 
process and 369 (93.9%) of those completed baseline surveys. To date, 174 (47.2%) of the 
participants who completed baseline surveys have also viewed the control education video. 
To date, 32 participants have withdrawn from the study because of a change in employment 
or employment duties.
Discussion
Increasingly, nursing scientists turn to multi-site research designs to recruit larger samples of 
participants efficiently, boost statistical power to detect meaningful effect sizes, strengthen 
external validity, and promote implementation of efficacious interventions (Donovan, Nolte, 
Edwards, & Wenzel, 2014). Emerging interest in promoting a culture of health has shifted 
the lens of health promotion and risk reduction research to population-level interventions 
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embedded in workplaces (Lavizzo-Mourey, 2015). These converging interests pose 
challenges and opportunities for nursing scientists. In our team’s two year experience 
conducting a multi-site randomized controlled trial with registered nurse participants, we 
identified five important considerations for PIs and study team members who plan to 
conduct similar studies.
Our project benefited from strong support from senior nursing leaders during study planning 
and execution. This approach was used successfully in a prior project that involved chief 
nursing officer participation in the research project, but required the trust and candor of 
registered nurse participants (Friese, Siefert, Thomas-Frost, Walker, & Ponte, 2015). While 
leaders should pledge and demonstrate support for research projects, they must also take 
care to avoid direct involvement in the project when employees are participants. In our case, 
the leaders understood that direct knowledge of which employees were participating could 
threaten the candor of responses.
We were fortunate to have thoughtful input from the IRB to pursue strategies for rigorous 
and efficient human subjects review. Not all projects will qualify for not-engaged 
designation. Recent policy changes regarding single IRB review of studies funded by the 
National Institutes of Health (NIH) may benefit researchers conducting multi-site research 
(National Institutes of Health, 2016b). Careful delineation of responsibilities, including clear 
roles and responsibilities of study site key contacts and primary site study team members, 
will be essential for smooth implementation as regulations and IRB policies change 
(O’Rourke et al., 2015).
While our change to our human subjects protections plan offered efficiency, we also had to 
adjust the planned roles of on-site study coordinators. They became less involved in 
participant recruitment and instead served as study facilitators. Yet we found their feedback 
about their organization and the experiences of their colleagues as study participants crucial 
for study success. They provided essential recommendations to amend study procedures and 
try alternate approaches, particularly when considering viewing educational materials. 
Implementation scientists have cited absence of local support as a key contributor to failed 
implementation (Scott et al., 2009). Our experience would support this observation. Another 
argument for on-site study staff is to meet the New Knowledge component for the American 
Nurses Credentialing Center Magnet Recognition Program (American Nurses Credentialing 
Center, 2013). One portion of the evaluation criteria assesses whether clinical nurses 
participate in nursing research within the organization. Our project assisted study sites 
pursuing Magnet recognition show evidence of ongoing nursing research.
To date, few investigators have documented internet access and browser compatibility issues 
across research sites. The study team’s experiences with these challenges are novel, and pose 
important implications for future researchers. Internet-based educational interventions are 
ubiquitous given the high rates of access and increased use of smartphones. Despite 
technological advances, healthcare facilities lag behind other employment sectors due to 
privacy and cost concerns (HIMSS Analytics, 2015). Information technology resources and 
policies vary substantially across healthcare settings, which makes intervention website 
design more complicated. Despite an upfront capabilities survey, careful planning, and pilot 
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testing, several of our sites had difficulties with the website as initially designed. We 
encourage investigators to plan for additional programming costs after initial design for such 
a contingency. Our measurement of intervention fidelity is limited to data capture from the 
website; additional procedures to include direct observation of participants would strengthen 
the validity of our findings.
Several aspects of the current inquiry merit comment. First, the DEFENS study sites are 
primarily elite cancer cancers with robust research capacity. PIs conducting research in sites 
with less research capacity and experience may encounter different challenges. Multi-site 
projects consume substantial fiscal and human resource costs. Close collaboration with 
grants management professionals, coupled with frequent engagement with research sites, 
will minimize the impact of subsequent surprises. In our experience, senior leadership 
engagement coupled with pledging non-financial resources were key to overcoming 
obstacles. Yet we realize there are underappreciated costs to sites for research participation. 
Assuring that the project aligns with the organizational mission is an important consideration 
in recruiting sites.
While our investigation focused on a project that included employee participants, many of 
the findings are generalizable to sites where patients are participants. It is unclear how 
current revisions to NIH policy will impact future human subjects protection plans in 
projects not funded by NIH. Yet our findings, which include perspectives of the primary 
research team and leaders at participating sites, have notable relevance to the nursing 
scientists as they plan and conduct complex multi-site intervention studies.
Conclusions
As the third year of the study began, the DEFENS study team has successfully recruited 393 
participants from 12 cancer centers across the country to understand factors that predict 
nurses’ use of personal protective equipment when handling hazardous drugs. Our team 
identified senior leadership engagement, on-site study coordinator participation, and 
partnership with IRB staff as key factors in the project’s success. PIs planning future web-
based, multi-site intervention studies should pay careful attention to each site’s internet 
capabilities and policies, anticipate information technology challenges, and work closely 
with their team to overcome financial challenges. Anticipation and proactive actions to 
address these issues will improve the likelihood of successful study activation and 
participation.
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